Federal vaccine expert turned whistleblower says 'lives are at stake' if Trump doesn't coordinate with Biden
Dr. Rick Bright, the federal vaccine expert who blew the whistle on a politicized coronavirus response, said that "lives are at stake" if the outgoing Trump administration does not coordinate with President-elect Joe Biden's transition team over vaccine distribution.
"Lives are at stake here," Bright, an immunologist who was recently named a member of Biden's transition COVID-19 advisory board, told ABC News chief anchor George Stephanopoulos in an interview Tuesday on "Good Morning America."
"If we miss this opportunity to coordinate now, we could experience hiccups or delays that really we don't need to see," he added. "Americans deserve a smooth transition so we can make sure to save their lives from this pandemic."
The Biden transition team planned to meet with vaccine manufacturers this week, and Bright, whose life's work has been developing vaccines, said he hoped they would provide more detailed data from their trials.
"We really do need to see the data, the full data set," he said. That data set needs to be made available to the FDA and to other scientists. President-elect Biden has said all along he’s going to let science lead the way, and so it's critical that we are able to see that in a transparent way and the best recommendations from those scientists are made for the FDA, and then that information is carried forward to the American public."
Bright said it's important to see if the full data set shows the vaccine to be safe and effective in people of all populations, because the early, interim data could just prove efficacy for a certain population.
When asked whether the Trump administration's "Operation Warp Speed" vaccine production program should get any credit for the speed with which vaccines have been developed, Bright instead credited investments in vaccine technology made under the Obama administration.
Bright is the former director of the Biomedical Advanced Research and Development Authority, the federal agency charged with overseeing the rapid production of a vaccine to fight the novel coronavirus. He filed a whistleblower complaint in May, alleging he was ousted because he resisted pressure to allow widespread use of hydroxychloroquine, the malaria drug that President Donald Trump was touting as treatment for COVID-19.
ABC News' Ben Gittleson contributed to this report.